NYSE:ABT
Abbott Laboratories
- Stock
Last Close
124.95
06/11 21:32
Market Cap
179.27B
Beta: 0.66
Volume Today
6.76M
Avg: 5.40M
PE Ratio
34.38
PFCF: 133.28
Dividend Yield
1.86%
Payout:31.19%
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 2.67B - | 2.62B 1.76% | 2.52B 3.99% | 3.02B 19.91% | 3.70B 22.57% | 4.06B 9.67% | 4.66B 14.99% | 5.08B 9.02% | 5.67B 11.42% | 3.09B 45.52% | |
average payables | 1.04B - | 1.07B 2.63% | 1.13B 5.31% | 1.79B 58.48% | 2.69B 50.20% | 3.11B 15.81% | 3.60B 15.59% | 4.18B 16.06% | 4.51B 7.91% | 2.30B 48.90% | |
average receivables | 3.79B - | 3.50B 7.50% | 3.33B 4.83% | 4.25B 27.47% | 5.22B 22.76% | 5.30B 1.69% | 5.92B 11.61% | 6.45B 8.97% | 7.68B 19.12% | 4.44B 42.21% | |
book value per share | 14.27 - | 14.40 0.90% | 13.94 3.19% | 17.72 27.08% | 17.39 1.88% | 17.64 1.45% | 18.51 4.94% | 20.29 9.65% | 20.71 2.06% | 21.47 3.67% | |
capex per share | -0.71 - | -0.75 5.54% | -0.76 0.98% | -0.65 14.47% | -0.79 21.98% | -0.93 17.04% | -1.23 32.25% | -1.07 13.06% | -1.00 6.11% | ||
capex to depreciation | -0.70 - | -0.75 8.39% | -0.83 9.87% | -0.38 54.65% | -0.43 13.19% | -0.54 27.80% | -0.65 20.40% | -0.53 18.58% | -0.54 2.09% | ||
capex to operating cash flow | -0.29 - | -0.37 27.70% | -0.35 6.48% | -0.20 41.78% | -0.22 8.59% | -0.27 20.64% | -0.28 3.22% | -0.18 35.05% | -0.19 3.64% | ||
capex to revenue | -0.05 - | -0.05 2.27% | -0.05 1.18% | -0.04 22.92% | -0.05 10.01% | -0.05 12.62% | -0.06 22.52% | -0.04 30.43% | -0.04 6.98% | ||
cash per share | 2.96 - | 4.16 40.63% | 12.75 206.49% | 5.51 56.76% | 2.33 57.77% | 2.35 0.93% | 4.04 71.81% | 5.81 43.96% | 5.74 1.17% | 4.01 30.09% | |
days of inventory on hand | 104.65 - | 108.45 3.63% | 98.45 9.22% | 106.54 8.22% | 109.05 2.35% | 119.06 9.19% | 121.93 2.41% | 101.54 16.72% | 117.71 15.92% | ||
days payables outstanding | 42.13 - | 45.11 7.07% | 47.65 5.63% | 71.07 49.15% | 85.46 20.26% | 89.71 4.97% | 96.00 7.01% | 86.80 9.59% | 87.85 1.21% | ||
days sales outstanding | 64.65 - | 61.14 5.42% | 56.85 7.02% | 69.95 23.04% | 61.86 11.57% | 62.07 0.34% | 67.65 8.99% | 54.97 18.74% | 74.26 35.09% | ||
debt to assets | 0.19 - | 0.22 14.81% | 0.42 91.48% | 0.37 12.36% | 0.29 20.46% | 0.28 4.45% | 0.27 2.69% | 0.25 6.68% | 0.24 5.84% | ||
debt to equity | 0.36 - | 0.42 16.44% | 1.07 152.50% | 0.90 15.65% | 0.64 29.08% | 0.61 5.19% | 0.60 1.38% | 0.53 11.43% | 0.48 9.03% | ||
dividend yield | 0.02 - | 0.02 10.38% | 0.03 24.68% | 0.02 31.70% | 0.02 16.34% | 0.01 4.62% | 0.01 10.97% | 0.01 2.30% | 0.02 31.94% | ||
earnings yield | 0.03 - | 0.07 98.79% | 0.02 63.00% | 0.00 80.63% | 0.02 289.02% | 0.02 29.15% | 0.02 3.76% | 0.03 22.88% | 0.04 25.18% | 0.03 16.93% | |
enterprise value | 71.67B - | 70.14B 2.14% | 59.96B 14.51% | 118.02B 96.84% | 142.71B 20.91% | 168.13B 17.81% | 206.74B 22.97% | 257.48B 24.54% | 202.30B 21.43% | 200.28B 1.00% | |
enterprise value over ebitda | 22.83 - | 18.71 18.04% | 21.49 14.87% | 23.83 10.90% | 23.92 0.34% | 25.25 5.57% | 27.23 7.86% | 23.95 12.04% | 18.91 21.04% | 20.16 6.61% | |
ev to operating cash flow | 19.50 - | 23.65 21.25% | 18.72 20.84% | 21.19 13.19% | 22.65 6.90% | 27.40 20.96% | 26.17 4.50% | 24.45 6.58% | 21.11 13.63% | ||
ev to sales | 3.54 - | 3.44 2.90% | 2.88 16.35% | 4.31 49.86% | 4.67 8.31% | 5.27 12.92% | 5.97 13.36% | 5.98 0.06% | 4.63 22.47% | 4.99 7.75% | |
free cash flow per share | 1.72 - | 1.26 26.84% | 1.41 12.16% | 2.54 79.94% | 2.79 9.86% | 2.55 8.67% | 3.23 26.63% | 4.90 51.70% | 4.41 10.12% | ||
free cash flow yield | 0.04 - | 0.03 26.67% | 0.04 31.14% | 0.04 21.11% | 0.04 13.32% | 0.03 23.95% | 0.03 0.46% | 0.03 18.01% | 0.04 15.21% | ||
graham net net | -7.40 - | -6.74 8.90% | -6.46 4.16% | -17.09 164.44% | -15.14 11.43% | -14.88 1.74% | -14.16 4.81% | -12.18 14.01% | -9.95 18.32% | 4.01 140.36% | |
graham number | 22.06 - | 31.20 41.45% | 17.27 44.65% | 10.44 39.52% | 22.97 119.94% | 28.81 25.44% | 32.51 12.83% | 42.78 31.60% | 42.71 0.17% | 39.69 7.08% | |
income quality | 1.61 - | 1.87 16.45% | 2.33 24.33% | 11.68 401.28% | 2.66 77.22% | 1.66 37.45% | 1.76 5.62% | 1.49 15.25% | 1.38 7.23% | ||
intangibles to total assets | 0.39 - | 0.37 6.48% | 0.23 37.03% | 0.60 157.09% | 0.63 5.29% | 0.59 5.69% | 0.53 10.36% | 0.48 9.93% | 0.45 6.61% | 0 100% | |
interest coverage | 35.60 - | 49.43 38.84% | 9.59 80.59% | 2.21 76.93% | 5.06 128.78% | 7.87 55.42% | 10.71 36.17% | 17.19 60.48% | 22.30 29.69% | ||
interest debt per share | 5.25 - | 6.15 17.16% | 15.17 146.55% | 16.46 8.55% | 11.56 29.81% | 11.05 4.40% | 11.38 2.98% | 11.05 2.85% | 10.21 7.58% | ||
inventory turnover | 3.49 - | 3.37 3.50% | 3.71 10.16% | 3.43 7.59% | 3.35 2.30% | 3.07 8.41% | 2.99 2.35% | 3.59 20.08% | 3.10 13.73% | ||
invested capital | 0.36 - | 0.42 16.44% | 1.07 152.50% | 0.90 15.65% | 0.64 29.08% | 0.61 5.19% | 0.60 1.38% | 0.53 11.43% | 0.48 9.03% | ||
market cap | 67.89B - | 66.14B 2.58% | 56.57B 14.46% | 99.51B 75.89% | 126.98B 27.61% | 153.09B 20.56% | 193.93B 26.68% | 248.28B 28.02% | 194.46B 21.67% | 193.23B 0.63% | |
net current asset value | -4.38B - | -5.77B 31.79% | -5.17B 10.28% | -25.00B 383.38% | -21.82B 12.74% | -20.92B 4.12% | -19.10B 8.68% | -14.93B 21.83% | -12.31B 17.57% | 7.05B 157.25% | |
net debt to ebitda | 1.20 - | 1.07 11.42% | 1.21 13.75% | 3.74 208.11% | 2.63 29.54% | 2.26 14.31% | 1.69 25.26% | 0.86 49.24% | 0.73 14.49% | 0.71 3.14% | |
net income per share | 1.51 - | 3.00 98.30% | 0.95 68.35% | 0.27 71.22% | 1.35 393.04% | 2.09 55.09% | 2.54 21.31% | 4.01 57.95% | 3.91 2.35% | 3.26 16.71% | |
operating cash flow per share | 2.44 - | 2.01 17.35% | 2.17 7.98% | 3.19 46.90% | 3.59 12.33% | 3.48 2.98% | 4.46 28.13% | 5.97 33.85% | 5.41 9.41% | ||
payables turnover | 8.66 - | 8.09 6.60% | 7.66 5.33% | 5.14 32.95% | 4.27 16.85% | 4.07 4.74% | 3.80 6.55% | 4.21 10.61% | 4.15 1.20% | ||
receivables turnover | 5.65 - | 5.97 5.73% | 6.42 7.54% | 5.22 18.72% | 5.90 13.08% | 5.88 0.34% | 5.40 8.25% | 6.64 23.06% | 4.92 25.98% | ||
research and ddevelopement to revenue | 0.07 - | 0.07 3.65% | 0.07 0.96% | 0.08 19.66% | 0.08 7.82% | 0.08 1.68% | 0.07 8.57% | 0.06 8.97% | 0.07 3.93% | 0.07 3.30% | |
return on tangible assets | 0.09 - | 0.17 85.94% | 0.03 79.61% | 0.02 55.20% | 0.09 511.32% | 0.13 40.56% | 0.13 0.85% | 0.18 36.43% | 0.17 6.62% | ||
revenue per share | 13.43 - | 13.86 3.20% | 14.16 2.18% | 15.71 10.95% | 17.42 10.88% | 18.10 3.93% | 19.54 7.94% | 24.42 24.97% | 24.65 0.93% | 22.85 7.30% | |
roe | 0.11 - | 0.21 96.53% | 0.07 67.31% | 0.02 77.35% | 0.08 402.50% | 0.12 52.88% | 0.14 15.61% | 0.20 44.05% | 0.19 4.31% | 0.15 19.66% | |
roic | 0.06 - | 0.08 28.46% | 0.06 27.51% | 0.00 91.76% | 0.05 997.93% | 0.08 58.47% | 0.09 11.90% | 0.13 43.94% | 0.13 3.07% | 0.15 20.91% | |
sales general and administrative to revenue | 0.32 - | 0.33 3.10% | 0.32 3.78% | 0.33 4.03% | 0.32 4.27% | ||||||
shareholders equity per share | 14.27 - | 14.40 0.90% | 13.94 3.19% | 17.72 27.08% | 17.39 1.88% | 17.64 1.45% | 18.51 4.94% | 20.29 9.65% | 20.71 2.06% | 21.47 3.67% | |
stock based compensation to revenue | 0.01 - | 0.01 17.78% | 0.01 3.88% | 0.01 0.29% | 0.02 5.24% | 0.02 4.28% | 0.02 3.02% | 0.01 5.82% | 0.02 5.61% | ||
tangible asset value | 5.37B - | 6.13B 13.99% | 8.49B 38.67% | -14.39B 269.45% | -11.47B 20.29% | -8.92B 22.27% | -5.53B 38.05% | 54M 100.98% | 3.65B 6,662.96% | ||
tangible book value per share | 3.56 - | 4.16 16.73% | 5.77 38.65% | -8.26 243.14% | -6.54 20.84% | -5.06 22.57% | -3.12 38.36% | 0.03 100.98% | 2.06 6,635.67% | ||
working capital | 4.73B - | 4.97B 5.08% | 20.12B 304.83% | 11.23B 44.15% | 5.62B 49.98% | 4.80B 14.52% | 8.53B 77.64% | 11.13B 30.47% | 9.73B 12.57% | 7.05B 27.61% |
All numbers in USD (except ratios and percentages)